Valo Overview

  • Year Founded
  • 2019

Year Founded

  • Status
  • Private

  • Employees
  • 186

Employees

  • Latest Deal Type
  • Series C

  • Latest Deal Amount
  • $100M

  • Investors
  • 16

Valo General Information

Description

Developer of a health tech platform designed to facilitate the drug discovery and development process. The company's platform integrates machine learning, cloud computing, and data to analyze human data to uncover previously unsuspected associations between genetic markers and disease with a human-centric framing, enabling clients from the healthcare industry to develop oncology, neurodegenerative, and cardiovascular disease drugs.

Contact Information

Formerly Known As
Integral Health
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • 75 Hayden Road
  • Suite 200
  • Lexington, MA 02421
  • United States
Primary Industry
Discovery Tools (Healthcare)
Corporate Office
  • 75 Hayden Road
  • Suite 200
  • Lexington, MA 02421
  • United States

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Valo Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
5. Later Stage VC (Series C) 28-Oct-2022 $100M Completed Generating Revenue
4. Early Stage VC (Series B) 11-Mar-2021 Completed Generating Revenue
3. Debt - General 01-May-2020 Completed Stealth
2. Debt - General 01-Jan-2020 $60M $160M Completed Stealth
1. Early Stage VC (Series A) 05-Jul-2019 $100M $100M Completed Stealth
To view Valo’s complete valuation and funding history, request access »

VC Exit Predictor

See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.

Opportunity Score

Calculated using Exit Type probabilities, the company’s stage, and PitchBook’s historical returns data.

Exit Type

Evaluates the likelihood of a successful exit for investors, and the most likely exit type.

Valo Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Developer of a health tech platform designed to facilitate the drug discovery and development process. The company's pla
Discovery Tools (Healthcare)
Lexington, MA
186 As of 2025

Montreal, Canada
 

San Mateo, CA
 
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Valo Competitors (13)

One of Valo’s 13 competitors is Chemical Computing Group, a Private Equity-Backed company based in Montreal, Canada.

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Chemical Computing Group Private Equity-Backed Montreal, Canada
Genesis Molecular AI Venture Capital-Backed San Mateo, CA
insitro Venture Capital-Backed South San Francisco, CA
Verge Labs Venture Capital-Backed San Francisco, CA
Exscientia Formerly VC-backed Oxford, United Kingdom
You’re viewing 5 of 13 competitors. Get the full list »

Valo Patents

Valo Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
WO-2026212788-A1 Systems and methods for generating targeted molecular property models Pending 31-Mar-2025
WO-2026080227-A1 Systems and methods for curation of diverse biological and/or chemical data Pending 11-Oct-2024
WO-2025193576-A1 Method and system for synthetic data generation Pending 14-Mar-2024
AU-2024395540-A1 S1p 1 receptor agonists and uses thereof Pending 05-Dec-2023
EP-4820009-A1 S1p 1 receptor agonists and uses thereof Pending 05-Dec-2023 C07D413/14
To view Valo’s complete patent history, request access »

Valo Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Valo Investors (16)

Investor Name Investor Type Holding Investor Since Participating Rounds
HBM Healthcare Investments Venture Capital Minority
Titan Holdings Venture Capital Minority
Atinum Investment Venture Capital Minority
E Squared Capital Management Hedge Fund Minority
Hercules Capital (San Mateo) Lender/Debt Provider Minority
You’re viewing 5 of 16 investors. Get the full list »

Valo Investments & Acquisitions (5)

Valo’s most recent deal was a Early Stage VC with Basecamp Research for . The deal was made on 01-Dec-2022.

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
Basecamp Research 01-Dec-2022 Early Stage VC Discovery Tools (Healthcare)
TARA Biosystems 01-Apr-2022 Merger/Acquisition Drug Discovery
Courier Therapeutics 28-May-2021 Merger/Acquisition Drug Discovery
Numerate 01-Nov-2019 Merger/Acquisition Discovery Tools (Healthcare)
TrialzOWN 01-Mar-2019 Merger/Acquisition Other Pharmaceuticals and Biotechnology
To view Valo’s complete investments and acquisitions history, request access »

Valo Affiliates

Subsidiaries (1)

Name Industry Location Year Founded
Numerate San Francisco, CA 2007

Valo FAQs

  • When was Valo founded?

    Valo was founded in 2019.

  • Where is Valo headquartered?

    Valo is headquartered in Lexington, MA.

  • What is the size of Valo?

    Valo has 186 total employees.

  • What industry is Valo in?

    Valo’s primary industry is Discovery Tools (Healthcare).

  • Is Valo a private or public company?

    Valo is a Private company.

  • What is the current valuation of Valo?

    The current valuation of Valo is .

  • What is Valo’s current revenue?

    The current revenue for Valo is .

  • How much funding has Valo raised over time?

    Valo has raised $595M.

  • Who are Valo’s investors?

    HBM Healthcare Investments, Titan Holdings, Atinum Investment, E Squared Capital Management, and Hercules Capital (San Mateo) are 5 of 16 investors who have invested in Valo.

  • Who are Valo’s competitors?

    Chemical Computing Group, Genesis Molecular AI, insitro, Verge Labs, and Exscientia are some of the 13 competitors of Valo.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process